What just happened? Crows attack Rapunzel’s hair at Disneyland — viral moment unfoldsA Rapunzel animatronic at Tokyo DisneySea has gone viral after being attacked by crows during a live attraction. The incident took place in...
ZYT readies AI that can outdrive its own CEO on Shenzhen streetsZYT, a spin-off from Chinese drone maker DJI, will demonstrate what it calls a "mobility foundation model" at the Beijing auto show in Apri...
Uber, Momenta to begin self-driving testing in Munich next yearUber has been attempting to establish a strong foothold in the robotaxi industry through partnerships with companies including Alphabet's W...
Mercedes to use Momenta software in 4 models, accelerate China comeback, sources sayMercedes-Benz is planning a $75-million investment in autonomous driving startup Momenta to enhance its market share in China. This partner...
Patent infringement lawsuit filed against Natco by Johnson & Johnson, MomentaHomegrown pharma firm Natco on Wednesday said Johnson & Johnson and Momenta Pharmaceuticals have filed a patent infringement lawsuit agains...
GM invests in Chinese autonomous driving startup MomentaAutomakers and technology firms are investing billions of dollars in autonomous driving, aiming to take an early lead in what many consider...
General Motors invests $300 million in Chinese autonomous driving startup MomentaGM is also making vehicles with SAIC Motor, which has also invested in Momenta. Momenta, which holds a permit for gathering high-definition...
Oncology solutions company Mitra Biotech gets $40 millionBoston and Bengaluru-based Mitra Biotech develops and provides novel technologies that personalise cancer treatment.
Digital lending startups enter classrooms to grow businessWhile it might push up interest rates, in many cases institutes are open to bearing the interest rates, since quick financing options give ...
FinMomenta introduces corporate HR loansWith corporate HR loans, employees can avail any loan starting from Rs 50,000 to Rs 5,00,000 with minimum interest rate of 11.50% to 25% pe...
Setback to Natco pharma; US Supreme Court sends Teva patent case to Federal CircuitThe US Supreme Court has sent back the patent case related to Teva's multiple sclerosis drug Copaxone for a review by the Federal Circuit.
Teva may move court against Dr Reddy's for patent infringementThe Israeli drug maker already is involved in various legal battles with other drug firms over the patent litigations of Copaxone.
Natco Pharma cracks 19% as US justices agrees to hear Teva's Copaxone appealThe decision by the Supreme Court comes at a time when Teva is switching its daily version of Copaxone to twice a week version.
Natco Pharma rallies over 8% as US Court rejects stay request on CopaxoneShares of Natco Pharma surged higher after the US Supreme Court rejected rival Teva Pharma’s request for stay on Copaxone drug.
Celebrating failure paves way for greater achievement, says Kamran ElahianSerial entrepreneur Kamran Elahian has co-founded 10 firms, of which 6 were successes. But he treasures his “first and biggest” failure the...
- Natco Pharma loses patent case against Teva Pharmaceutical Industries of anti-sclerosis drug
Natco Pharma has lost a patent litigation against Israel's Teva Pharmaceutical Industries in the US over multiple sclerosis treatment drug,...
- Natco Pharma plunges after NY court verdict
Shares of Natco Pharma are witnessing selling pressure after a New York court ruled in favour of Teva in a patent case against the company.